stockportfolio.pro
Catalyst Pharmaceuticals, Inc. Revenue 2002–2025
Catalyst Pharmaceuticals, Inc. (CPRX) annual revenue by fiscal year, computed from SEC filings.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $588.99M | +19.8% |
| FY 2024 | $491.73M | +23.5% |
| FY 2023 | $398.20M | +85.9% |
| FY 2022 | $214.20M | +52.1% |
| FY 2021 | $140.83M | +18.3% |
| FY 2020 | $119.07M | +16.4% |
| FY 2019 | $102.31M | +20361.3% |
| FY 2018 | $500,000 | — |
| FY 2017 | $0 | — |
| FY 2016 | $0 | — |
| FY 2015 | $0 | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | — |
| FY 2010 | $0 | — |
| FY 2009 | $0 | — |
| FY 2008 | $0 | — |
| FY 2007 | $0 | — |
| FY 2006 | $0 | — |
| FY 2005 | $0 | — |
| FY 2004 | $0 | — |
| FY 2003 | $0 | — |
| FY 2002 | $0 | — |
Source: Catalyst Pharmaceuticals, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Catalyst Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCatalyst Pharmaceuticals, Inc. — frequently asked questions
What is Catalyst Pharmaceuticals, Inc.'s revenue?
Catalyst Pharmaceuticals, Inc. (CPRX) reported revenue of $588.99M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Catalyst Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.